MENINGOCOCCAL POLYSACCHARIDE

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-2011
0119812011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
BACKGROUND Meningococcal polysaccharide (MPLS) vaccines protect against Serogroup C disease, but do not produce an immune… (More)
Is this relevant?
Review
2007
Review
2007
In 2005, a quadrivalent meningococcal conjugate vaccine was licensed in the United States for persons aged 11-55 years of age… (More)
Is this relevant?
Review
2006
Review
2006
BACKGROUND Meningococcal polysaccharide (MPLS) vaccines protect against Serogroup C disease, but do not produce an immune… (More)
Is this relevant?
2001
2001
Forty-four adult BMT recipients transplanted from an HLA-identical sibling donor were randomized to receive meningococcal… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1997
1997
Lack of primary immune response in severe combined immunodeficient (SCID) mice engrafted with human peripheral blood lymphocytes… (More)
Is this relevant?
1989
1989
Pretreatment of mice with subimmunogenic doses of meningococcal polysaccharide (MP), Pseudomonas aeruginosa lipopolysaccharide… (More)
Is this relevant?
1981
1981
Serum samples were collected from 120 healthy adult volunteers (105 Caucasians and 15 Negros) before and after immunization with… (More)
Is this relevant?